Get the Stockscreener App
124.79
4.30%
5.14
Repligen Corp stock is traded at $124.79, with a volume of 775.43K.
It is up +4.30% in the last 24 hours and up +9.35% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$119.65
Open:
$120.88
24h Volume:
775.43K
Relative Volume:
0.97
Market Cap:
$7.02B
Revenue:
$633.51M
Net Income/Loss:
$-8.10M
P/E Ratio:
-402.55
EPS:
-0.31
Net Cash Flow:
$131.26M
1W Performance:
+0.36%
1M Performance:
+9.35%
6M Performance:
-21.51%
1Y Performance:
-15.73%
1-Day Range:
$119.90
$127.21
1-Week Range:
$119.29
$127.48
52-Week Range:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Compare RGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
124.79 | 6.98B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-25 | Resumed | Stephens | Overweight |
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-29-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-18-25 | Initiated | Evercore ISI | In-line |
| Feb-10-25 | Initiated | TD Cowen | Buy |
| Dec-17-24 | Initiated | Canaccord Genuity | Hold |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Repligen Corporation stock momentum explainedTrade Performance Summary & Risk Controlled Swing Alerts - Newser
How to build a custom watchlist for Repligen CorporationJuly 2025 Market Mood & Real-Time Chart Pattern Alerts - Newser
What’s next for Repligen Corporation stock priceSell Signal & Stock Market Timing Techniques - Newser
Is Repligen Corporation impacted by rising ratesMarket Rally & Expert Curated Trade Ideas - sundaytimes.kr
Using economic indicators to assess Repligen Corporation potentialMarket Trend Review & Smart Swing Trading Alerts - Newser
What’s the outlook for Repligen Corporation’s sectorWeekly Profit Report & Reliable Breakout Forecasts - 선데이타임즈
Will earnings trigger a reversal in Repligen CorporationJuly 2025 PostEarnings & Pattern Based Trade Signal System - Newser
Long term hold vs stop loss in Repligen CorporationJuly 2025 Update & Fast Exit Strategy with Risk Control - Newser
Repligen Corporation: From Pandemic Surge to Sustainable Bioprocessing Innovation - AInvest
Vanguard Group Inc. Decreases Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by PNC Financial Services Group Inc. - Defense World
Can machine learning forecast Repligen Corporation recovery2025 AllTime Highs & Free Technical Confirmation Trade Alerts - Newser
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know - Yahoo Finance
Using fundamentals and technicals on Repligen CorporationPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Why Repligen Corporation stock attracts strong analyst attentionWatch List & AI Driven Stock Price Forecasts - Newser
Repligen Corporation stock prediction for this weekAsset Growth Pattern and Return Summary - Newser
How to monitor Repligen Corporation with trend dashboardsFree Sector Based Breakout Stock Forecast - Newser
Can trapped investors hope for a rebound in Repligen CorporationShort-Term Profit Alert With Entry Forecast - Newser
AMN Healthcare Services, NeoGenomics, Acadia Healthcare, BrightSpring Health Services, and Repligen Shares Are Soaring, What You Need To Know - Yahoo Finance
Repligen director Madaus buys $201k in shares By Investing.com - Investing.com South Africa
Repligen director Madaus buys $201k in shares - Investing.com
RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty - Yahoo Finance
5 Must-Read Analyst Questions From Repligen’s Q2 Earnings Call - Yahoo Finance
Chuck Royce's Portfolio Shifts: Analyzing Recent 13F Filing and Investment Strategy - AInvest
Will Repligen Corporation benefit from macro trendsFree Portfolio Diversification Stock Ideas - Newser
Repligen CorporationCommon Stock (Nasdaq:RGEN) Stock Quote - FinancialContent
Will Repligen Corporation rebound enough to break evenFree Pattern Breakout Entry Stock Forecast - Newser
Repligen Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Volatility clustering patterns for Repligen CorporationBuy Signal System Based on Price Action - Newser
How Repligen Corporation stock performs during market volatilityAutomated AI Forecast with Trading Alerts - Newser
Exit strategy if you’re trapped in Repligen CorporationSafe Entry Zone Based on Chart Analysis - Newser
Repligen 2025 Q2 Earnings Net Income Surges 160.2% - AInvest
Sector ETF performance correlation with Repligen CorporationPattern Recognition Tool for ROI Investors - Newser
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus
Live market analysis of Repligen CorporationDaily Entry Opportunity Forecasting Tool - Newser
REPLIGEN CORP SEC 10-Q Report - TradingView
Pattern recognition hints at Repligen Corporation upsideFree Fast Gaining Stock Screener Report - Newser
Repligen (NASDAQ:RGEN) Investors Are Sitting on a Loss of 53% If They Invested Three Years Ago - 富途牛牛
Visual analytics tools that track Repligen Corporation performanceInvestment Roadmap for High Potential Stocks - Newser
Fund Update: GENEVA CAPITAL MANAGEMENT LLC added 343,991 shares of REPLIGEN ($RGEN) to their portfolio - Quiver Quantitative
What Fibonacci levels say about Repligen Corporation reboundFree Access to Smart Investment Tips - Newser
Geneva Capital Management LLC Buys 7,958 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Why is Repligen Corporation stock attracting strong analyst attentionUnlock exclusive trading strategies for gains - Jammu Links News
Can Repligen Corporation recover in the next quarterBuy Signal Forecast With Short-Term Data - Newser
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Repligen Corp Stock (RGEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hunt Anthony | Director |
May 15 '25 |
Sale |
123.71 |
26,447 |
3,271,688 |
109,854 |
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):